Specialty Pharmacy

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Top news of the week in oncology and cancer drug development.

Interference with transcription factor activity may lead to the development of novel disease therapeutics.

Pharmaceutical Care Management Association states that direct and indirect remuneration fees lower premium costs.

Uterine cancers disseminated by surgical device.

Study opens doors for more precise RA treatments.

Roughly half of MS patients had hyposmia at the beginning of the study.

Lung cancer demonstration project examines the feasibility of a screening program for veterans.

Combination treatment reduces head and neck cancer deaths by 20%.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Emflaza treats patients 5 years and older with DMD.

Gene-editing tool shows promise treating genetic diseases.

Manufacturers will present clinical trial results at the upcoming HIV medical meeting.

Glecaprevir/pribrentasvir well-tolerated in patients with HCV genotype 1.

A change from fingolimod to alemtuzumab caused significant disease activity in patients with MS.

Gut antibody imbalance may impact immune response to HIV.

Hypoxic tumor microenvironments influence the fate of disseminated tumor cells.

Top news of the day from across the health care landscape.

For patients with HIV, liver disease is a major cause of morbidity and mortality.

Do direct and indirect remuneration fees adversely affect the health care industry?

DIR fees continue to generate controversy for pharmacy stakeholders.

The prevalence of cirrhosis has increased by nearly 40% in patients with HCV.

Big data could allow physicians to take action before a patient with cancer needs to visit an emergency hospital.

Aerobic exercise increases hematologic indices in patients with RA.

Macrophages disable protective protein, leaving an open window for HIV infection.

African Americans with breast cancer have a 40% higher death rate than European-Americans.

Top news of the day from across the health care landscape.